|
Management
Board of Directors
Press Releases
Technology Partners
Transaction Partners |
|
Lâle White
Executive Chairman and Founder, XIFIN®, Inc.
Ms. White has been a Company director since 1997.
|
| |
Thomas H. Adams, Ph.D.
Chairman and CEO, Leucadia Technologies and Chairman Emeritus, Genta, Inc.
Dr. Adams has served in his present position at Leucadia Technologies, a privately
held medical-device company, since 1998. In 1989 Dr. Adams founded Genta, Inc., a publicly held
biotechnology company in the field of antisense technology, and served as its CEO until 1997. Dr. Adams
founded Gen-Probe, Inc. in 1984 and served as its Chief Executive Officer and Chairman until its
acquisition by Chugai Biopharmaceuticals, Inc. in 1989. Before founding Gen-Probe, Dr. Adams was
Senior Vice President of Research and Development at Hybritech. Dr. Adams currently serves as a
director of Invitrogen, Inc., La Jolla Pharmaceutical Company and Bio-Mems. He has been a Company
director since 1997.
|
| |
James H. Berglund
Managing Director & General Partner, Enterprise Partners Venture Capital
Dr. Berglund has held his current position at Enterprise Partners Venture Capital,
a leading Southern California venture capital firm, since 1985. Prior to that time, Dr. Berglund was
President and a director of Continuous Curve Contact Lenses, Inc., a publicly traded company that was
acquired by Revlon Consumer Products Corporation in 1980. He is a board member and compensation
committee member of several private companies and a director of Captiva Software Corporation, a
publicly traded company. Dr. Berglund has been a Company director since 2003.
|
| |
Charles M. Blalack
Chairman and CEO of Blalack and Company
Blalack and Company is a registered investment advisor that Mr. Blalack founded in 1969.
Mr. Blalack is currently a director at Advanced Micro Devices, Corticon and The Ensign Group, Inc. He has
been a Company director since 2000.
|
| |
David C. Flaugh
Formerly Senior Executive Vice President and Chief Operating Officer, Laboratory
Corporation of America and its predecessor National Health Laboratories. Mr. Flaugh has been a
Company director since 1997.
|
| |
Judd Jessup
Judd Jessup brings over 30 years experience in managing and building successful
healthcare companies. While CEO of US Labs he grew revenues to $75 MM before successfully negotiating
its sale to Laboratory Corporation of America (LabCorp) in 2005. Prior to that, Judd was President of
the HMO Division of FHP International, which provided healthcare to more than 1.8 million members in 11
states. He joined FHP in 1994, when FHP acquired TakeCare Inc., an HMO operating in California, Colorado,
Illinois and Ohio, where Judd had been President since 1987. Judd is credited with TakeCare's growth
from a 150,000 member privately held HMO in Northern California to a multi-state, publicly traded
organization with 790,000 members and $1.1 billion in annual revenue. Currently, Judd serves on the Board
of Directors for Corvel Corporation, a publicly held workers compensation utilization management company
and NovaMed Holdings, Inc., a publicly held eye-care services provider. Judd earned his BA degree from
Knox College in Illinois and his MBA from the University of Denver.
|
| |
M. David Titus
Managing Partner, Windward Ventures
David Titus is co-founder and Managing Director of Windward Ventures. In addition to
directing the overall development of the firm, he is responsible for a number of investments in the software
field. Mr. Titus has been a director of over 25 companies, including two public companies. He is currently
a director of several private companies, including Akonix Systems, Streamload and Syntricity. He is also a
member of the Executive Committee for the CONNECT program in San Diego and a member of the Venture Capital
Advisory Board of the San Diego Venture Group. Mr. Titus was formerly an officer of the Western Association
of Venture Capitalists.
Prior to founding Windward Ventures, Mr. Titus was a General Partner and Managing
Director of Corporate Finance for Technology Funding, a $250 million venture capital firm, where he was
responsible for directing all new investment activity from 1988 through 1992. Mr. Titus was also a co-founder
and Senior Vice President of Silicon Valley Bank, a highly successful bank with headquarters in Santa Clara,
California. Mr. Titus has a BA from University of California, Santa Barbara.
|
| |
Peter Roshko
General Partner, Boulder Ventures
Mr. Roshko has over 18 years of venture capital and consulting expertise. He was
General Partner at Mohr, Davidow Ventures for nine years where he concentrated in software, medical
devices and services. He was a board member of Vantive Corporation for nine years from founding
through IPO and subsequent sale to PeopleSoft. Mr. Roshko is currently a board member of Trust
Company of America, Finali and f4 Technologies. Mr. Roshko has been a Company director since 2000.
|
|
|
|
|
|
|
